跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Duobaclin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Duobaclin
Approved
STANDARD
Duobaclin
BioRx Pharma Labs LLP
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5dc87193cdc8558e
Company
BioRx Pharma Labs LLP
Type
Standard
Approval Details
Approval Id
5dc87193cdc8558e
Drug Approval Philippines Name
Duobaclin
Product Name
Duobaclin
Registration Number
DRP-6930-08
Brand Name
Duobaclin
Generic Name
Ampicillin (As Sodium) + Sulbactam (As Sodium)
Dosage Form
Powder For Injection (Iv/Im)
Dosage Strength
500mg/250mg
Manufacturer
BioRx Pharma Labs LLP
Importer
Ambica International Corporation
Distributor
Euparex Pharmaceuticals Inc.
Issuance Date
28 June 2021
Expiry Date
25 November 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5dc87193cdc8558e
Type
Standard
Back to Philippines FDA Approvals